HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
WEDNESDAY, Jan. 24, 2018 (HealthDay News) -- The incidence of squamous cell carcinoma (SCC) affecting the eyelids is rising in England, according to a study published online Jan. 23 in the British Journal of Ophthalmology.
James Wawrzynski, from Moorfields Eye Hospital NHS Foundation Trust in the United Kingdom, and colleagues used data from the National Cancer Registration and Analysis Service to identify all cases of eyelid SCC in England between 2000 and 2014.
The researchers found that there were 4,022 patients in England diagnosed with a first episode of SCC affecting the eyelids during the 15-year study period. The age-standardized number of reported cases rose by a mean of 0.0137 cases per 100,000 population per year, which is equivalent to approximately a 2-percent-per-year increase in SCC incidence. There was an exponential correlation between age and incidence, with an approximate doubling of the risk for every decade over 60 years of age. In men, the relative risk of eyelid SCC was 1.9 compared to women. SCC risk was not associated with social deprivation quintile by income.
"We show that the epidemiology of eyelid SCC has strong similarities with SCC of the skin and with eyelid basal cell carcinoma but less so with cutaneous melanoma," the authors write. "The data presented here represent the only recent comprehensive evaluation of the demographics of eyelid SCC in England over more than a decade."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 28, 2022